Liaoning, China

Yaopeng Zhao


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yaopeng Zhao

Introduction

Yaopeng Zhao is a notable inventor based in Liaoning, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target muscarinic receptors. His work has implications for treating various diseases, showcasing the potential of his inventions in the pharmaceutical industry.

Latest Patents

Yaopeng Zhao holds a patent for a compound titled "2-(2,2-diarylethyl)-cyclic amine derivative or salt, synthesis method, application and composition thereof." This patent describes a synthesis method and application for a derivative that exhibits good M-receptor antagonistic activity. The biological activity tests indicate that this compound can be utilized as an active component in drugs aimed at treating diseases such as asthma, chronic obstructive pulmonary disease (COPD), overactive bladder (OAB), and several mental health disorders.

Career Highlights

Zhao is affiliated with the Chinese Academy of Sciences, where he conducts research and development in the field of medicinal chemistry. His work is characterized by a focus on innovative solutions to complex health issues, contributing to advancements in drug development.

Collaborations

Yaopeng Zhao has collaborated with notable colleagues, including Xinmiao Liang and Yanfang Liu. These partnerships enhance the research efforts and broaden the scope of their collective work in medicinal chemistry.

Conclusion

Yaopeng Zhao's contributions to the field of medicinal chemistry through his innovative patent demonstrate his commitment to advancing healthcare solutions. His work not only highlights the importance of research in drug development but also showcases the potential for new treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…